{"database": "lobbying", "table": "lobbying_activities", "rows": [[1340276, "41b17573-b001-49b3-b181-b9f3bfa040e7", "Q4", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)", 2012, "fourth_quarter", "PHA", "**see addendum page Importation of prescription drugs (S.319/H.R. 147)\nNASPER reauthorization (H.R. 866)\nPill Mill  Crackdown Act (H.R. 1065/S. 1760/S. 2297)\nDrug Abuse (S. 507)\nDrug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651)\nRx Pedigree (H.R. 3026/PL 112-144)\nCargo/Product Theft (S. 1002/H.R. 4223)\nPrescription Drug Monitoring Program  (H.R. 2254/H.R. 4292/PL 112-144)\nCounterfeit Drugs (S. 1886/H.R. 3668/PL 112-144)\n\n***, no specific bills, supply chain integrity, prescription drug abuse", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2013-01-17T15:27:08.213000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1340276"], "units": {}, "query_ms": 77.77785102371126, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}